MHLW to Issue Development Requests for New Indications for 6 Meds including Stivarga

A council of the Ministry of Health, Labor and Welfare (MHLW) determined on December 21 that there are high medical needs for six APIs, including Bayer Yakuhin’s Stivarga (regorafenib). The MHLW will now issue development requests to each relevant drug...read more